UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association study in multiple populations Journal article
Lin G.-W., Xu C., Chen K., Huang H.-Q., Chen J., Song B., Chan J.K.C., Li W., Liu W., Shih L.-Y., Chuang W.-Y., Kim W.S., Tan W., Peng R.-J., Laurensia Y., Cheah D.M.Z., Huang D., Cheng C.L., Su Y.-J., Tan S.-Y., Ng S.-B., Tang T.P.L., Han K., Wang V.Y.-F., Jia W.-H., Pei Z., Li Y.-J., Gao S., Shi Y., Hu Z., Zhang F., Zhang B., Zeng Y.-X., Shen H., He L., Ong C.K., Lim S.T., Chanock S., Kwong Y.-L., Lin D., Rothman N., Khor C.C., Lan Q., Bei J.-X., Au W.-Y., Chiu B., Fan L., Li Z., LAM T.H., Liang R., Yeh S.-P., Xu J., Ip D.K.M., Li G., Xu G., Wang X., Bai O., Cai Q.-Q., Xia Y., Chen J.-R., Luo C.-L., Xiong X.-Y., Zeng Y., Wei P.-P., Liu C.-J., Liu Y.-X., Cao Y.-L., He S., Liu Y., Ha J.C.H., Khoo L.P., Kee R.X., Tan J., Liu Y., Zhang F., Feng Y., Rao H., Chng W.J., Chan J.Y.S., Somasundaram N.D., Tao M., Ras M.F.B.H., Yeoh K.-W., Goh Y.T., Ong S.Y., Grigoropoulos N.F., Wong E.K.Y., Pang J.W.L., Lim J.Q., Chia B.K.H., Kim S.J., Yoon S.E., Choi S., Kuo C.-Y., Chen T.-Y., Su Y.-C., Huang W.-T., Lee M.-Y., Yao W., Ngan K.-C., Liu H., Lee H., Yip S.-F., Liu J., Li J., Rabkin C.S., Berndt S., Bassig B., Hu W., Zhao M., Li Y., Zhai Q., Shao Z., Qiu L., Wang J., Xu F.-P., Chen L., Hou Y., Xu S., Huang Z., Xie M., Li M., Zhong S., Zhang Y., Gu D., Wang X., Foo J.N., Li Z., Dai J., Sun L., Wang Z., Liu H., Zhou H., Sun Y., Koh W.-P., Heng C.-K., Hong C.S., Ahn J., Park K.H., Tin A., Gu J., Xia X., Li B., Yu X., International NKTCL Working Group. Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association study in multiple populations[J]. The Lancet Oncology, 2020, 21(2), 306-316.
Authors:  Lin G.-W.;  Xu C.;  Chen K.;  Huang H.-Q.;  Chen J.; et al.
Favorite | TC[WOS]:49 TC[Scopus]:52  IF:41.6/42.2 | Submit date:2022/06/15
Targeting the heparin-binding domain of fibroblast growth factor receptor 1 as a potential cancer therapy Journal article
Ling L., Tan S.K., Goh T.H., Cheung E., Nurcombe V., van Wijnen A.J., Cool S.M.. Targeting the heparin-binding domain of fibroblast growth factor receptor 1 as a potential cancer therapy[J]. Molecular Cancer, 2015, 14(1).
Authors:  Ling L.;  Tan S.K.;  Goh T.H.;  Cheung E.;  Nurcombe V.; et al.
Favorite | TC[WOS]:18 TC[Scopus]:19  IF:27.7/31.3 | Submit date:2018/12/17
Cell Death  Cell Growth  Heparan Sulfate  Neutralizing Antibody  Targeted Therapy  Tumor